KDIGO Clinical Practice Guideline for Aenemia in Chronic Kidney Disease
Kidney Int (2012).
Core Recommendations:
- Diagnose anemia in children with CKD if Hb concentration is
<11.0 g/dl in children 0.5–5 years,
<11.5 g/dl in children 5–12 years,
<12.0 g/dl in children 12–15 years,
<13.0 g/dl in males and <12.0 g/dl in females >15 years. - For all pediatric CKD patients with anemia not on iron or ESA therapy, oral iron (or IV iron in HD patients) administration is recommended when TSAT is <20% and ferritin is <100 microgram/l.
- For all children on ESA therapy who are not receiving iron supplementation, oral iron (or IV iron in HD patients) administration is recommended to maintain TSAT >20% and ferritin >100 microgram/l.
- Evaluate iron status (TSAT and ferritin) at least every 3 months during ESA therapy, including the decision to start or continue iron therapy.
- In children receiving ESA therapy Hb should be in the range of 11.0 to 12.0 g/dl.
Comments by evaluators: